484 related articles for article (PubMed ID: 9234798)
1. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge.
Pal S; Theodor I; Peterson EM; de la Maza LM
Infect Immun; 1997 Aug; 65(8):3361-9. PubMed ID: 9234798
[TBL] [Abstract][Full Text] [Related]
2. Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge.
Pal S; Luke CJ; Barbour AG; Peterson EM; de la Maza LM
Vaccine; 2003 Mar; 21(13-14):1455-65. PubMed ID: 12615442
[TBL] [Abstract][Full Text] [Related]
3. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge.
Pal S; Peterson EM; Rappuoli R; Ratti G; de la Maza LM
Vaccine; 2006 Feb; 24(6):766-75. PubMed ID: 16199110
[TBL] [Abstract][Full Text] [Related]
4. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge.
Pal S; Theodor I; Peterson EM; de la Maza LM
Infect Immun; 2001 Oct; 69(10):6240-7. PubMed ID: 11553566
[TBL] [Abstract][Full Text] [Related]
5. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challenge.
Pal S; Davis HL; Peterson EM; de la Maza LM
Infect Immun; 2002 Sep; 70(9):4812-7. PubMed ID: 12183524
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria.
Pal S; Peterson EM; de la Maza LM
Infect Immun; 2005 Dec; 73(12):8153-60. PubMed ID: 16299310
[TBL] [Abstract][Full Text] [Related]
7. Partial protection against genital reinfection by immunization of guinea-pigs with isolated outer-membrane proteins of the chlamydial agent of guinea-pig inclusion conjunctivitis.
Batteiger BE; Rank RG; Bavoil PM; Soderberg LS
J Gen Microbiol; 1993 Dec; 139(12):2965-72. PubMed ID: 7510322
[TBL] [Abstract][Full Text] [Related]
8. Intranasal immunization induces long-term protection in mice against a Chlamydia trachomatis genital challenge.
Pal S; Peterson EM; de la Maza LM
Infect Immun; 1996 Dec; 64(12):5341-8. PubMed ID: 8945586
[TBL] [Abstract][Full Text] [Related]
9. Vaccination of mice with DNA plasmids coding for the Chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge.
Pal S; Barnhart KM; Wei Q; Abai AM; Peterson EM; de la Maza LM
Vaccine; 1999 Feb; 17(5):459-65. PubMed ID: 10073724
[TBL] [Abstract][Full Text] [Related]
10. A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge.
Pal S; Tatarenkova OV; de la Maza LM
Immunology; 2015 Nov; 146(3):432-43. PubMed ID: 26423798
[TBL] [Abstract][Full Text] [Related]
11. Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes.
Igietseme JU; Murdin A
Infect Immun; 2000 Dec; 68(12):6798-806. PubMed ID: 11083798
[TBL] [Abstract][Full Text] [Related]
12. Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis.
Pal S; Fielder TJ; Peterson EM; de la Maza LM
Infect Immun; 1994 Aug; 62(8):3354-62. PubMed ID: 8039906
[TBL] [Abstract][Full Text] [Related]
13. Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein.
Sun G; Pal S; Weiland J; Peterson EM; de la Maza LM
Vaccine; 2009 Aug; 27(36):5020-5. PubMed ID: 19446590
[TBL] [Abstract][Full Text] [Related]
14. A chlamydial major outer membrane protein extract as a trachoma vaccine candidate.
Campos M; Pal S; O'Brien TP; Taylor HR; Prendergast RA; Whittum-Hudson JA
Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1477-91. PubMed ID: 7601629
[TBL] [Abstract][Full Text] [Related]
15. Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection.
Su H; Parnell M; Caldwell HD
Vaccine; 1995 Aug; 13(11):1023-32. PubMed ID: 8525685
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with the recombinant major outer membrane protein elicits antibodies to the constant domains and induces cross-serovar protection against intranasal challenge with Chlamydia trachomatis.
Tifrea DF; Ralli-Jain P; Pal S; de la Maza LM
Infect Immun; 2013 May; 81(5):1741-50. PubMed ID: 23478318
[TBL] [Abstract][Full Text] [Related]
17. Increased immunoaccessibility of MOMP epitopes in a vaccine formulated with amphipols may account for the very robust protection elicited against a vaginal challenge with Chlamydia muridarum.
Tifrea DF; Pal S; Popot JL; Cocco MJ; de la Maza LM
J Immunol; 2014 Jun; 192(11):5201-13. PubMed ID: 24778450
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine.
Ifere GO; He Q; Igietseme JU; Ananaba GA; Lyn D; Lubitz W; Kellar KL; Black CM; Eko FO
J Microbiol Immunol Infect; 2007 Jun; 40(3):188-200. PubMed ID: 17639158
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge.
Pal S; Theodor I; Peterson EM; de la Maza LM
Vaccine; 1997 Apr; 15(5):575-82. PubMed ID: 9160528
[TBL] [Abstract][Full Text] [Related]
20. Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection.
Singh SR; Hulett K; Pillai SR; Dennis VA; Oh MK; Scissum-Gunn K
Vaccine; 2006 Feb; 24(8):1213-24. PubMed ID: 16194585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
